about
microRNAs in kidneys: biogenesis, regulation, and pathophysiological rolesCRNDE: A Long Non-Coding RNA Involved in CanceR, Neurobiology, and DEvelopmentMultiscale integration of -omic, imaging, and clinical data in biomedical informatics.Comparison and evaluation of pathway-level aggregation methods of gene expression data.Bayesian network prior: network analysis of biological data using external knowledge.Recent advances in the management of Wilms' tumor.Birt-Hogg-Dubé renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression.MicroRNAs of the mir-17~92 cluster regulate multiple aspects of pancreatic tumor development and progression.Systematic Analysis of the Expression of the Mitochondrial ATP Synthase (Complex V) Subunits in Clear Cell Renal Cell Carcinoma.Molecular sub-classification of renal epithelial tumors using meta-analysis of gene expression microarrays.Biomarkers for drug-induced renal damage and nephrotoxicity-an overview for applied toxicology.Non-viral nanocarriers for siRNA delivery in breast cancer.Deletions of 16q in Wilms tumors localize to blastemal-anaplastic cells and are associated with reduced expression of the IRXB renal tubulogenesis gene cluster.mCOPA: analysis of heterogeneous features in cancer expression data.MicroRNAs and their applications in kidney diseasesIntegrated microRNA and mRNA expression profiling in a rat colon carcinogenesis model: effect of a chemo-protective dietThe yin and yang of kidney development and Wilms' tumorsA systematic analysis of the 3'UTR of HNF4A mRNA reveals an interplay of regulatory elements including miRNA target sites.Urinary Exosomal microRNA-451-5p Is a Potential Early Biomarker of Diabetic Nephropathy in Rats.A Murine Model of K-RAS and β-Catenin Induced Renal Tumors Expresses High Levels of E2F1 and Resembles Human Wilms TumorEvidence that Igf2 down-regulation in postnatal tissues and up-regulation in malignancies is driven by transcription factor E2f3Combining miRNA and mRNA Expression Profiles in Wilms Tumor Subtypes.MicroRNAs in renal development.Clear cell renal cell carcinoma associated microRNA expression signatures identified by an integrated bioinformatics analysis.Computational challenges in miRNA target predictions: to be or not to be a true target?Epigenetics and the control of epithelial sodium channel expression in collecting duct.Alterations of MicroRNAs in Solid Cancers and Their Prognostic Value.Systematic expression analysis of the mitochondrial complex III subunits identifies UQCRC1 as biomarker in clear cell renal cell carcinoma.Meta-analysis of gene expression and integrin-associated signaling pathways in papillary renal cell carcinoma subtypes.MicroRNAs: potential regulators of renal development genes that contribute to CAKUT.Nucleic acid-based tissue biomarkers of urologic malignancies.Biomarkers to detect Wilms tumors in pediatric patients: where are we now?The roles of microRNAs in Wilms' tumors.The genetic factors contributing to the development of Wilm's tumor and their clinical utility in its diagnosis and prognosis.MicroRNA expression patterns and signalling pathways in the development and progression of childhood solid tumours.MYC regulates the antitumor immune response through CD47 and PD-L1Functional genomics identifies novel genes essential for clear cell renal cell carcinoma tumor cell proliferation and migration.Neuronal pentraxin 2 supports clear cell renal cell carcinoma by activating the AMPA-selective glutamate receptor-4The interleukin 6 receptor is a direct transcriptional target of E2F3 in prostate tumor derived cells.Oncogenic role of miR-483-3p at the IGF2/483 locus.
P2860
Q28387168-05F530F2-DAB4-4AB4-BB32-C520A489F3DBQ28391523-FDF555ED-D978-430F-8A01-7AD74EC7FC08Q30581136-1FADAB79-0797-40EA-B734-5B475AF87F6BQ30584130-D919E961-BA75-479A-87F8-36251C597A64Q30692229-AE2CDDB8-BF0E-471F-96DC-EE42D097E3D6Q33772198-A15C3185-2568-46CD-941F-C85B1D1F8497Q33772820-4D00C920-443B-4EDB-B38D-1C2A12BE5418Q33829355-A9B65D71-2875-4E1D-88FC-C548E3403CC0Q33869708-5521CDA3-37BC-49D8-8FDC-C403519C3D29Q33982903-FDAD8D74-0A82-4597-BF70-37B236DD302EQ34039254-20B721EE-635F-4436-82DF-C181BF260768Q34079608-6343BD45-27F8-4772-96DA-9D7E26C5C2BAQ34254608-B725523F-5BF7-4695-A9D2-F819440845E7Q34502379-506410C7-7D51-4D54-8093-F5567A230ECEQ34696427-E9059714-88CC-4579-92F7-9C49BAF613E2Q35033649-62FF1613-FD2B-404B-B234-99286DC19CF6Q35173260-5518E7EA-7625-431B-8937-112F9D2C53AAQ35582977-B157AC2C-69E0-47EF-AD54-9C41D197A030Q35996301-67C2C369-56D0-4CF4-961D-BE38B818A9A3Q36663009-AD33E763-1FDD-4622-861E-E83D3A3786B7Q36762442-6BB851C2-2B55-48C9-90F1-16D63F6D2928Q36846957-14133E9F-78DD-4C3A-AFD3-07FCFA960D5DQ37037682-D6CE82E4-AAAB-4EAF-9F17-6D1375037EB8Q37088462-6E439ED4-7F89-4FAC-94C6-D7EBA30BF9FEQ37235215-7090934E-0794-41E4-BD07-A0C77EC0A44DQ37279817-4D50CE22-6DB8-4907-A3C6-8C9DC8DC19C4Q37328429-525A8B04-54DB-4D35-BB3B-825D7F444CE1Q37699265-3471253E-F63A-4AA2-903C-1EE79A56F728Q37708931-A225B5A7-D77C-4693-A730-96827BC67EE9Q38133419-2FD960E8-736C-49EF-8CE0-9CD82792AC33Q38216131-FF11EB28-773E-4109-B415-D8A48C294D56Q38559338-0CC14D28-2013-40AF-9DE1-7E13C3A4437DQ38658528-C6446366-9C2E-49B2-9855-68ECF7527865Q38764772-FB549A5E-7AC7-4BDE-A3B2-43C7E9D9F31EQ38768383-A82A7E63-3D7E-40B0-A506-BA9B18418AC7Q38787131-7CC2E8EF-5BD9-404A-A0F4-5AC98FF392AAQ38979602-1ADAAAC9-B15B-472A-B6CB-4569C29653D9Q38981597-7B62CCDF-6C31-4042-A604-4BAC1F46F1A3Q39491165-AF298135-E467-41BC-9B5A-A1748FBA56E6Q39715206-C20FB93B-E5A8-4FBC-AB23-E530EF6315C0
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
The E2F3-Oncomir-1 axis is activated in Wilms' tumor.
@ast
The E2F3-Oncomir-1 axis is activated in Wilms' tumor.
@en
type
label
The E2F3-Oncomir-1 axis is activated in Wilms' tumor.
@ast
The E2F3-Oncomir-1 axis is activated in Wilms' tumor.
@en
prefLabel
The E2F3-Oncomir-1 axis is activated in Wilms' tumor.
@ast
The E2F3-Oncomir-1 axis is activated in Wilms' tumor.
@en
P2093
P2860
P1433
P1476
The E2F3-Oncomir-1 axis is activated in Wilms' tumor.
@en
P2093
Albert Cornelius
David Petillo
Eric J Kort
Kyle A Furge
Leslie Farber
Maria Tretiakova
Ximing J Yang
P2860
P304
P356
10.1158/0008-5472.CAN-08-0592
P407
P50
P577
2008-06-01T00:00:00Z